The top stories on Tuesday:
**Elan takeover:** in the latest twist in the Royalty Pharma/Elan saga, Royalty Pharma has withdrawn its request for a judicial review of the ruling that forces it to lapse its takeover offer for Elan under certain conditions, and has confirmed that its offer has now lapsed.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team